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Lipolysis provides metabolic fuel; however, aberrant
adipose lipolysis results in ectopic lipid accumula-
tion and lipotoxicity. While adipose triacylglycerol
lipase (ATGL) catalyzes the first step of lipolysis, its
regulation is not fully understood. Here, we demon-
strate that adipocyte Snail1 suppresses both ATGL
expression and lipolysis. Adipose Snail1 levels are
higher in fed mice than in fasted mice and higher in
obese mice as opposed to lean mice. Insulin in-
creases Snail1 levels in both murine and human adi-
pocytes, wherein Snail1 binds to the ATGL promoter
to repress its expression. Importantly, adipocyte-
specific deletion of Snail1 increases adipose ATGL
expression and lipolysis, resulting in decreased fat
mass and increased liver fat content in mice fed
either a normal chow diet or a high-fat diet. Thus,
we have identified a Snail1-ATGL axis that regulates
adipose lipolysis and fatty acid release, thereby gov-
erning lipid partitioning between adipose and non-
adipose tissues.
INTRODUCTION
White adipose tissue (WAT) stores metabolic fuel as triacylgly-
cerol (TAG) in lipid droplets (LDs). During fasting, exercise, or
cold exposure, adipose lipolysis is activated by the sympathetic
nervous system (SNS) to release free fatty acids (FFAs) that po-
wer biological activities. Lipolysis also controls lipid partitioning
between adipose and non-adipose tissues, and aberrant adi-
pose lipolysis increases ectopic lipid accumulation and lipotox-
icity in non-adipose tissue (e.g., the liver), thereby promoting
metabolic disease (Fuchs et al., 2014; Morigny et al., 2016).
Adipose triglyceride lipase (ATGL), also termed desnutrin or
patalin-like phospholipase-domain-containing 2 (PNPLA2), cat-
alyzes the first step of lipolysis in both rodents and humans (Bez-Cell Repor
This is an open access article under the CC BY-Naire et al., 2009; Young and Zechner, 2013). Adipose ATGL is
activated upon SNS-stimulated activation of the cyclic AMP
(cAMP)/protein kinase A (PKA) pathway, thereby mediating lipol-
ysis to release FFAs as key metabolic fuel during fasting (Ahma-
dian et al., 2011; Granneman et al., 2009; Pagnon et al., 2012;
Sahu-Osen et al., 2015; Xie et al., 2014; Yamaguchi et al.,
2007). Whole-body deletion of ATGL blocks adipose lipolysis,
and ATGL null mice die prematurely (Haemmerle et al., 2006).
Adipocyte-specific deletion of ATGL similarly blocks adipose
lipolysis, thus protecting against high-fat diet (HFD)-induced liver
steatosis (Ahmadian et al., 2011; Schoiswohl et al., 2015; Wu
et al., 2012). Conversely, adipocyte-specific overexpression of
ATGL increases adipose lipolysis, thus decreasing fat mass in
ATGL transgenic mice (Ahmadian et al., 2009).
Insulin, a primary metabolic hormone, inhibits lipolysis,
thereby allowing WAT to store TAG in the fed state. Insulin
rapidly inhibits ATGL activation by suppressing the cAMP/PKA
pathway, which may account for acute suppression of lipolysis
(Berggreen et al., 2009; Degerman et al., 1998; DiPilato et al.,
2015). Insulin also suppresses ATGL transcription in adipocytes
(Bartness et al., 2014; Chakrabarti and Kandror, 2009; Chakra-
barti et al., 2013; Eguchi et al., 2011; Kershaw et al., 2006; Kim
et al., 2006), likely contributing to the sustained suppression of
lipolysis. Expression of adipose ATGL is reduced in mice with
either genetic (ob/ob) or HFD-induced obesity (Kim et al.,
2006; Villena et al., 2004); reduction in adipose ATGL levels is ex-
pected to decrease adipose lipolysis, thereby protecting against
ectopic lipid accumulation and lipotoxicity.
Snail1 is a Snail transcription factor family (Snail1, Snail2, and
Snail3) member, and deletion of Snail1 is embryonic lethal
(Carver et al., 2001). Snail1 is known to promote epithelial-to-
mesenchymal transition (EMT) by suppressing the expression
of E-cadherin (Lin et al., 2014). Snail1 binds to the E2-
boxes (CAGGTG or CACCTG) of its target promoters, eliciting
transcriptionally repressive epigenetic modifications, including
H3K9 deacetylation, H3K4 demethylation, and H3K9 and
H3K27 methylation (Dong et al., 2013a; Herranz et al., 2008;
Lin et al., 2010; Peinado et al., 2004). Recent studies suggest
that Snail1 may be involved in metabolic regulation. Snail1ts 17, 2015–2027, November 15, 2016 ª 2016 The Author(s). 2015
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Insulin Stimulates Snail1 Expres-
sion in Both Mouse and Human Adipocytes
(A) 3T3-L1 preadipocytes differentiated into adi-
pocytes. Snail1 and adiponectin mRNA levels
were measured by qPCR and normalized to 36B4
expression; n = 6.
(B) 3T3-L1 preadipocytes and adipocytes were
treated with insulin (100 nM) for 48 hr. Snail1
expression was measured by qPCR and normal-
ized to 36B4 expression; n = 4.
(C) Human adipose stem cells differentiated into
adipocytes and stimulatedwith insulin (100 nM) for
5 hr. Snail1mRNA levels were measured by qPCR
and normalized to GAPDH levels; n = 3.
(D) 3T3-L1 adipocytes were stimulated with insulin
(100 nM) for 0–120 min. Cell extracts were im-
munoblotted with antibodies against Snail1,
phospho-Akt (pSer473), Akt, phospho-GSK3a/b
(pSer21/9), GSK3a/b, or tubulin.
(E) Primary adipocytes were prepared frommouse
eWAT and stimulated with 100 nM insulin for 2 hr.
Cell extracts were immunoblotted with the indi-
cated antibodies.
(F) Human adipose stem cells differentiated into
adipocytes and stimulatedwith insulin (100 nM) for
5 hr. Cell extracts were immunoblotted with the
indicated antibodies.
(G) 3T3-L1 adipocytes were pretreated with
Wortmannin (100 nM), LY294002 (10 mM), or
PD98059 (50 mM) for 30 min, and then stimulated
with insulin (100 nM) for additional 2 hr. Cell
extracts were immunoblotted with the indicated
antibodies.
(H) C57BL males (9 weeks) were randomly fed
(n = 7), fasted for 24 hr (n = 8), or refed for 3 hr after
24 hr of fasting (n = 8). Plasma insulin levels and
Snail1 mRNA levels in eWAT (normalized to 36B4
levels) were measured.
(I) C57BL males (12 weeks) were fasted overnight
and treated with insulin (2 U/kg body weight,
intraperitoneally [i.p.]) for 2 hr or 4 hr. eWAT ex-
tracts were immunoblotted with the indicated an-
tibodies, and Snail1 protein levels (normalized to
tubulin levels) and Akt phosphorylation (normal-
ized to total Akt levels) were quantified.
Values are mean ± SEM. *p < 0.05.suppresses the expression of PPARg, thereby inhibiting 3T3-L1
adipocyte differentiation (Batlle et al., 2013; Lee et al., 2013). In
cancer cells, Snail1 inhibits mitochondrial activity as well as the
expression of lipogenic (e.g., ChREBP, ACC, and FAS) and glu-
coneogenic (e.g., FBPase1) genes (Dong et al., 2013b; Jiang
et al., 2015a; Lee et al., 2012). However, the metabolic function
of Snail1 in vivo remains undefined. Herein, we demonstrate
that insulin potently stimulates Snail1 expression in WAT, where
it acts as a molecular brake to block lipolysis via the epigenetic
inhibition of ATGL expression. Consistent with its regulatory
role, adipocyte-specific deletion of Snail1 results in nonalcoholic
fatty liver disease (NAFLD) due to increased adipose lipolysis.2016 Cell Reports 17, 2015–2027, November 15, 2016Thus, adipose Snail1 operates as an epigenetic rheostat that
governs lipid metabolism and lipid partitioning between tissues.
RESULTS
Insulin Stimulation Increases Snail1 Levels in Both
Mouse and Human Adipocytes
Following the induction of 3T3-L1 adipocyte differentiation,
Snail1 and adiponectin expression levels were monitored by
qPCR. The expression of adiponectin (an adipocyte marker)
was undetectable in preadipocytes and progressively increased
from day 2 to day 6 after induction (Figure 1A). By contrast,
(legend on next page)
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Snail1 expression increased to its highest levels on day 2 and
gradually declined between day 2 and day 6 after induction (Fig-
ure 1A). Insulin stimulation significantly increased Snail1 mRNA
levels in 3T3-L1 preadipocytes and adipocytes (Figure 1B) and
in human adipose stem cell-derived adipocytes (Figure 1C).
Insulin receptor levels are higher in adipocytes than in preadipo-
cytes, potentially explaining the increased ability of insulin to
stimulate Snail1 expression in adipocytes. As expected, insulin
stimulated phosphorylation of Akt and GSK3a/b while markedly
increasing Snail1 protein in a time- and dose-dependent manner
(Figures 1D and S1A). Similarly, insulin stimulation increased
Snail1 levels in mouse primary adipocytes (Figure 1D) and hu-
man adipose stem cell-derived adipocytes (Figures 1F and
S1B). To gain insight into signaling pathways mediating insulin
action, 3T3-L1 adipocytes were pretreated with wortmannin
(phosphatidylinositol 3-kinase [PI3K] inhibitor), LY294002 (PI3K
inhibitor), or PD98059 (MEK inhibitor). Both wortmannin and
LY294002, but not PD98059, blocked the ability of insulin to in-
crease Snail1 levels (Figure 1G), indicating that PI 3-kinase
activity is required for insulin-stimulated Snail1 induction. To
determine whether insulin increases adipose Snail1 expression
in vivo, mice were fasted for 24 hr and then refed for 3 hr. Plasma
insulin levels were lower in the fasted group than in the fed or
refed group; accordingly, Snail1 expression in epididymal WAT
(eWAT) was significantly lower in fasted mice than in fed or refed
mice (Figure 1H). Similarly, whenmice were fasted overnight and
intraperitoneally injected with insulin, Snail1 protein (Figure 1I)
and mRNA (Figure S1C) levels increased in eWAT. Thus, insulin
potently stimulates expression of adipose Snail1 both in vitro
and in vivo.
Snail1 Cell-Autonomously Suppresses Adipose
Lipolysis
To determine whether Snail1 is involved in mediating insulin ac-
tion, 3T3-L1 adipocytes were transduced with Snail1 or GFP
(control) adenoviral expression vectors. With an infection effi-
ciency of 50%, Snail1 levels were increased modestly (Fig-
ure 2A). The transduced adipocytes were then stimulated with
isoproterenol (b-adrenergic receptor agonist) 2 days after
infection, and lipolysis was examined by measuring release of
FFAs and glycerol. Under these conditions, Snail1 overexpres-
sion significantly inhibited isoproterenol-stimulated lipolysis
(Figure 2B).
To next assess the degree to which endogenous Snail1 regu-
lates lipolysis, we generated adipocyte-specific Snail1 knockout
(AKO)mice (C57BL/6 background) by crossingSnail1flox/floxmice
with adiponectin-Cre drivers (Eguchi et al., 2011; Rowe et al.,
2009). Snail1 protein levels in eWAT were decreased in AKOFigure 2. Snail1 Suppresses Adipocyte Lipolysis
(A and B) 3T3-L1 adipocytes were infected with Snail1 or GFP adenoviruses for 2
tubulin. (B) Adipocytes were stimulated with isoproterenol (1 mM), and FFA and g
(C and D) Gonadal WAT explants were prepared from male (12 weeks) (AKO, n =
without isoproterenol (1 mM). FFA and glycerol release rates were measured (nor
(E) SVFs were prepared eWAT, differentiated into adipocytes, and stimulated wit
(F) EMSCswere isolated from Snail1flox/flox and AKOmales, differentiated to adipo
(basal) or presence of isoproterenol (0.1 mM). FFA release rates were measured
Values are mean ± SEM. *p < 0.05.
2018 Cell Reports 17, 2015–2027, November 15, 2016mice relative to Snail1flox/flox mice (Figure S2A), with residual
levels of Snail1 in AKO mice likely arising from stromal cell pop-
ulations in which the Snail1 gene would remain intact. As ex-
pected, Snail1 was disrupted in WAT, but not liver or kidney, in
AKO mice (Figure S2B). Further, Slug/Snail2 expression was un-
affected in Snail1 null adipose tissues (Figure S2C). To examine
the impact of Snail1 deletion on lipolysis, eWAT was isolated
from AKO and Snail1flox/flox mice and stimulated with isoproter-
enol. Both basal and isoproterenol-stimulated lipolysis rates
were significantly higher in AKO males and females (Figures 2C
and 2D). To further validate cell-autonomous suppression of
lipolysis by Snail1, epididymal stromal vascular fractions
(SVFs) were prepared from AKO and Snail1flox/flox mice and
differentiated into adipocytes. Differentiation efficiency was
similar between the AKO and Snail1flox/flox groups (Figure S2D).
Again, both basal and isoproterenol-stimulated lipolysis rates
were higher in the AKO group than in the Snail1flox/flox group (Fig-
ure 2E). To explore the possibility that Snail1 likewise mediates
insulin-induced suppression of lipolysis, ear mesenchymal
stem cells (EMSCs) were prepared from Snail1flox/flox and AKO
mice, differentiated into adipocytes (differentiation efficiency
50%), and stimulated with insulin in the presence of isoproter-
enol. While insulin suppressed isoproterenol-stimulated lipolysis
in WT adipocytes, the deletion of Snail1 decreased the ability of
insulin to suppress isoproterenol-stimulated lipolysis (Figure 2F).
Hence, insulin suppresses adipose lipolysis, at least in part, by
increasing adipocyte Snail1 levels.
Snail1 Suppresses ATGL Expression in Adipocytes
To gain insight into the potential mechanisms by which Snail1
suppresses lipolysis, we measured the levels of key proteins
regulating lipolysis in eWAT. Interestingly, ATGL protein levels
were markedly higher in AKO than Snail1flox/flox males and fe-
males, while hormone sensitive lipase (HSL) and perilipin-1
(PLIN1) levels were similar (Figure 3A). The mRNA levels of
ATGL, but not PLIN1 or HSL, were also significantly higher in
AKO mice (Figures 3B and 3C). Confirming previous reports
that Snail1 inhibits PPARg expression (Lee et al., 2013), PPARg
mRNA levels were also increased in AKO mice (Figure 3B). To
confirm these findings in vitro, we next isolated AKO and
Snail1flox/flox epididymal SVFs that were then differentiated into
adipocytes. Under these conditions, both ATGLmRNA and pro-
tein levels were significantly higher in AKO relative toSnail1flox/flox
adipocytes (Figures 3D and 3E). To further verify that Snail1 sup-
presses ATGL expression in a cell-autonomous fashion, we pre-
pared EMSCs from Snail1flox/flox mice, differentiated the stem
cells into adipocytes (Figure 3F), and then transduced the cells
with Cre (to delete Snail1) or b-galactosidase (b-gal; control)days. (A) Cell extracts were immunoblotted with antibodies against Snail1 or
lycerol releases were measured (normalized to protein levels); n = 3.
3; Snail1flox/flox, n = 5) and female (20 weeks, n = 4) mice and stimulated with or
malized to protein levels). FFA release rates (curve slopes) were calculated.
h isoproterenol (1 mM). FFA and glycerol release rates were measured; n = 6.
cytes, and stimulated with PBS vehicle or insulin (100 nM for 6 h) in the absence
(normalized to protein levels).
Figure 3. Snail1 Suppresses ATGL Expres-
sion in Adipocytes
(A–C) Gonadal WAT was prepared from AKO
and Snail1flox/flox male (12 weeks) and female
(20 weeks) mice. (A) WAT extracts were immuno-
blotted with the indicated antibodies, and protein
levels were quantified and normalized to tubulin
levels. (B and C) Gene expression (normalized to
36B4 expression) was measured by qPCR in
males (AKO: n = 3, Snail1flox/flox: n = 5) and females
(AKO: n = 4, Snail1flox/flox: n = 6).
(D and E) Epididymal SVFs differentiated into
adipocytes. (D) Gene expression (normalized to
36B4 expression) was measured by qPCR. n = 6.
(E) Adipocyte extracts were immunoblotted with
the indicated antibodies.
(F–H) EMSCs were isolated from Snail1flox/flox
males, differentiated to adipocytes, and infected
with Cre or b-gal adenoviruses for 2 days.
(F) Representative images of EMSC-derived adi-
pocytes. Scale bar: 100 mm. G. Adipocyte extracts
were immunoblotted with the indicated anti-
bodies. (H) ATGL expression (normalized to 36B4
expression) was measured by qPCR. n = 4.
Values are mean ± SEM. *p < 0.05.
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Figure 4. Snail1 Epigenetically Represses the ATGL Promoter
(A) A schematic representation of the mouse ATGL promoter (numbers indi-
cate positions from the transcription start site).
(B) ATGL luciferase reporter plasmids were cotransfected with Snail1
expression vectors into HEK293 cells. Luciferase activities were measured
48 hr after transfection and normalized to b-gal internal control.
(C) WT or mutant ATGL luciferase reporter plasmids were cotransfected with
Snail1 plasmids into HEK293 cells, and luciferase activities were measured
48 hr after transfection.
(D) WT or D123 ATGL luciferase reporter plasmids were transfected into 3T3-L
preadipocytes. Luciferase activities were measured 48 hr after transfection
and normalized to b-gal internal control.
(E) ChIP assays were performed using 3T3-L1 adipocytes. Snail1 occupancy
on the ATGL promoter (normalized to inputs) was quantified by qPCR.
(F) 3T3-L1 adipocytes were infected with Snail1 or GFP adenoviruses for 24 hr.
ATGL and CDH1 promoter H3K9 acetylation levels (normalized to inputs) were
quantified by ChIP-qPCR.
(G) Gonadal WAT was isolated from Snail1flox/flox (n = 3) and AKO (n = 3) fe-
males fed an HFD for 8 weeks. Snail1 occupancy and H3K9 acetylation levels
in the ATGL promoter were measured by ChIP-qPCR.
Values are mean ± SEM. *p < 0.05.
2020 Cell Reports 17, 2015–2027, November 15, 2016adenoviruses. Following Cre-mediated excision of the Snail1
alleles, ATGL mRNA and protein levels were increased (Figures
3G and 3H). To assess the contribution of Snail1 to suppression
of ATGL expression by insulin, wemeasured ATGL expression in
SVF-derived adipocytes treated with or without insulin. In line
with the above results, ATGL expression was higher in Snail1-
deficient adipocytes than in wild-type (WT) adipocytes under
both basal and insulin-stimulated conditions; surprisingly, insulin
failed to inhibit ATGL expression in either WT or Snail1 null adi-
pocytes under these conditions (Figure S2E). Taken together,
the above results support a model wherein endogenous Snail1
inhibits lipolysis at least in part by directly suppressing ATGL
expression.
Snail1 Epigenetically Represses the ATGL Promoter
The mouse ATGL promoter contains three putative Snail1 bind-
ing sites (E2 boxes) that are conserved in humans (Figure 4A).
Using mouse ATGL (from 987 to +71 bp) luciferase reporter
plasmids, Snail1 dose-dependently repressed ATGL promoter
activity (Figure 4B). When the three putative Snail1 binding sites
were mutated individually (D1, D2, or D3) or in combination
(D123), overexpression of Snail1 decreased D1, D2, and D3,
but not D123, luciferase activities (Figure 4C), suggesting that
each of the three sites is able to mediate Snail1 repression of
the ATGL promoter. Further, D123 luciferase activities were
significantly higher than WT ATGL luciferase activities in 3T3-
L1 cells (Figure 4D), indicating that endogenous Snail1 likely re-
presses the ATGL promoter through binding to these sites.
Indeed, physical interactions between Snail1 and the ATGL
promoter were confirmed using chromatin immunoprecipitation
(ChIP), wherein Snail1 bound to the ATGL promoter, but not the
NIK gene (negative controls), in 3T3-L1 adipocytes (Figure 4E).
Snail1 is known to repress target promoters through epige-
netic modifications (Lin et al., 2014). Hence, 3T3-L1 adipocytes
were transduced with Snail1 or GFP (control) adenoviruses,
and H3K9 acetylation was measured by ChIP. Overexpression
of Snail1 significantly reduced H3K9 acetylation levels in the pro-
moter regions of ATGL as well as CDH1, a well-characterized
(legend on next page)
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Snail1 target (Figure 4F) (Lin et al., 2014). To confirm that endog-
enous Snail1 binds to the ATGL promoter and suppresses
H3K9 acetylation, we measured Snail1 occupancy and H3K9
acetylation in the ATGL promoter of Snail1flox/flox versus AKO
mice. In AKO eWAT, Snail1 occupancy on the ATGL promoter
was significantly lower while H3K9 acetylation was significantly
higher relative to Snail1flox/flox eWAT (Figure 4G). Taken together,
these results are consistent with a model whereby Snail1 sup-
presses ATGL expression by epigenetically repressing the
ATGL promoter.
Obesity Is Associated with Increased Expression of
Snail1 in WAT
To assess the impact of obesogenic states on Snail1 expression,
adipose tissue Snail1 levels were measured in mice either fed an
HFD or rendered obese via genetic means (i.e., ob/ob). Snail1
mRNA levels in eWAT were significantly higher in both HFD-fed
mice and ob/ob mice relative to WT mice fed a standard chow
diet (Figure 5A). Likewise, Snail1 protein levels were also higher
in HFD-fed WT or ob/ob mice (Figures 5B and S3A). As plasma
insulin levels were significantly higher in HFD-fed mice or
ob/ob mice relative to chow-fed mice (Figure S3B), adipose tis-
sue Snail1 protein levels appeared to be positively correlated
with plasma insulin levels (Figure S3C). Given that obesity is
known to induce insulin resistance selectively in gluconeogenic,
but not lipogenic, pathways (Li et al., 2010), the insulin-Snail1
pathway may also remain relatively intact in obesity, thereby
allowing obesity-associated hyperinsulinemia to increase Snail1
expression levels in adipose tissues.
Adipose Snail1 Mediates Downregulation of Adipose
ATGL in Obesity
Confirming earlier studies, ATGL mRNA and protein levels were
lower in the eWAT of HFD-fed mice and ob/ob mice than in WT
mice fed a normal chow diet (Figures 5A and 5B) (Kim et al.,
2006; Villena et al., 2004). As ATGL expression was inversely
correlated with Snail1 expression in eWAT, we sought to deter-
mine whether the in vivo deletion of adipose Snail1might reverse
the obesity-associated downregulation of ATGL. As such, AKO
and Snail1flox/flox mice were fed an HFD, and ATGL levels were
measured in gonadal WAT by immunoblotting. Under these con-
ditions, ATGL, but not HSL or PLIN1, levels weremarkedly higher
in both AKO males and females relative to Snail1flox/flox males
and females, respectively (Figures 5C and S4A). Deletion of
adipocyte Snail1 fully reversed HFD-induced reduction in adi-
pose ATGL (Figure S4B). In agreement with these results, bothFigure 5. Adipocyte Snail1 Mediates Downregulation of Adipose ATGL
(A and B) C57BL male mice (7 weeks) were fed a standard chow diet or an HFD f
ATGL expression (normalized to 36B4 expression) was measured in eWAT by
munoblotted with the indicated antibodies.
(C) AKO and Snail1flox/flox mice were fed an HFD for 8 weeks (females) or 30 w
antibodies.
(D and E) AKO and Snail1flox/flox mice were fed an HFD for 8 weeks (females) or
(1 mM), and FFAs and glycerol release was measured (normalized to protein levels
females, n = 5.
(F) AKO and Snail1flox/floxmale mice (7 weeks) were fed an HFD for 20 weeks and
were measured; n = 11.
Values are mean ± SEM. *p < 0.05.
2022 Cell Reports 17, 2015–2027, November 15, 2016basal and isoproterenol-stimulated lipolysis rates of gonadal
WAT explants were also significantly higher in AKOmales and fe-
males relative to Snail1flox/flox mice (Figures 5D and 5E). Basal
lipolysis rates were very low in obese Snail1flox/flox female mice
under these conditions. We also measured lipolysis stimulated
by CL316243 (b3 adrenergic receptor agonist) in mice fed an
HFD, where blood FFA as well as glycerol levels were signifi-
cantly higher in AKO mice than in Snail1flox/flox mice 15 min after
CL316243 stimulation (Figure 5F). To corroborate these findings,
we assessed fasting-stimulated lipolysis in mice fed an HFD for
2 weeks. Blood FFA levels, after normalization to fat mass, were
higher in AKO mice than in Snail1flox/flox mice under fasted con-
ditions and remained higher in AKO mice after refeeding (Fig-
ure S5A). Fasting-induced increases in blood FFAs were also
higher in AKO mice than in Snail1flox/flox mice (Figure S5A). How-
ever, the differences were not statistically significant, presum-
ably due to a small sample size (AKO: n = 4; Snail1flox/flox:
n = 8). Together, these results demonstrate that obesity-associ-
ated factors, including hyperinsulinemia, increase the levels of
adipose Snail1, which in turn suppress ATGL expression.
Deletion of Adipose Snail1 Decreases WAT Mass and
White Adipocyte Size in Mice
While body weight, food intake, O2 consumption, and CO2 pro-
duction were similar between AKO and Snail1flox/flox male or
female mice (Figures S5B–S5D), whole-body fat content and
WAT weight were significantly lower in both AKO males and
females than in Snail1flox/flox controls on a normal chow diet (Fig-
ures 6A and 6B). Fat content and WAT weight were also signifi-
cantly lower in HFD-fed AKOmales and females than in HFD-fed
Snail1flox/flox mice (Figures 6C and 6D). The size of individual
white adipocytes was smaller in AKO than in Snail1flox/flox mice
(Figures 6E and 6F), suggesting that adipocyte Snail1 is a
determinant of adipocyte capacity to store TAG. Nevertheless,
insulin tolerance and glucose tolerance were similar between
Snail1flox/flox and AKO mice fed either a normal chow diet or an
HFD (Figure S6). Hence, adipose Snail1 regulates adipocyte
size and whole-body fat content, most likely in a process linked
to the suppression of ATGL-mediated lipolysis.
Adipocyte-Specific Deletion of Snail1 Increases Liver
Fat Content in Mice Fed Either a Normal Chow Diet or
an HFD
Given the demonstrated ability of endogenous Snail1 to repress
ATGL expression in vivo, the impact of Snail1 deletion on hepatic
lipid deposition was assessed. When visualized by Nile redin Obesity
or 13-14 weeks; ob/ob male mice were fed a normal chow diet. (A) Snail1 and
qPCR. Chow: n = 5, HFD: n = 6, ob/ob: n = 4. (B) eWAT extracts were im-
eeks (males). Gonadal WAT extracts were immunoblotted with the indicated
20 weeks (males). Gonadal WAT explants were stimulated with isoproterenol
). AKO males, n = 6; Snail1flox/floxmales, n = 6; AKO females, n = 3; Snail1flox/flox
injected with CL316243 (1 mg/kg body weight). Plasma FFA and glycerol levels
Figure 6. Adipocyte-Specific Deletion of Snail1
Decreases Adiposity and White Adipocyte Size
(A and B) Fat content and tissue weights in male (8 weeks)
and female (20 weeks) mice fed a normal chow diet.
gWAT, gonadal WAT; n = 6.
(C and D) Fat content and tissue weights in mice fed an
HFD for 8 weeks (females) or 30 weeks (males); n = 6.
(E and F) Females were fed an HFD for 8 weeks. (E) H&E
staining of gWAT. Scale bar, 100 mm. (F) Adipocyte sizes
were calculated and presented as percentage of total cell
number; n = 3.
Values are mean ± SEM. *p < 0.05.
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Figure 7. Adipocyte-Specific Deletion of Snail1 Promotes Hepatic Steatosis
(A and B) Mice (8 weeks) were fed a normal chow diet. (A) Nile red staining of male liver sections (overnight fasting). Scale bar, 100 mm. (B) Liver TAG and
cholesterol levels (normalized to liver weight). AKO males, n = 3; Snail1flox/flox males, n = 5; AKO females, n = 7; Snail1flox/flox females, n = 7.
(C and D) Mice were fed an HFD for 8 weeks (females) or 30 weeks (males). (C) Nile red staining of male liver sections (overnight fasting). Scale bar, 100 mm.
(D) Liver TAG and cholesterol levels (normalized to liver weight). AKO (n = 17) and Snail1flox/flox (n = 19) males were fasted for 24 hr; AKO (n = 3) and Snail1flox/flox
(n = 6) females were randomly fed.
(E) Gene expression (normalized to 36B4 expression) was measured in the liver by qPCR.
Values are mean ± SEM. *p < 0.05.staining, both LD number and size were increased in AKO mice
fed a normal chow diet (Figure 7A). Further, liver TAG levels were
also significantly higher in both AKO males and females than in
Snail1flox/flox males and females, respectively, while liver choles-
terol levels were similar (Figure 7B). Deletion of adipose Snail1
also markedly exacerbated HFD-induced hepatic steatosis in
both AKO males and females (Figures 7C and 7D). By contrast,
plasma, skeletal muscle, and kidney TAG levels were similar be-
tween Snail1flox/flox and AKO mice (Figures S4C and S4D).
Further, the expression of hepatic genes known to stimulate lipo-
genesis (e.g., SREBP1c, ChREBP, and Fasn), TAG synthesis
(e.g., DGAT1 and DGAT2), lipolysis (e.g., ATGL and HSL), fatty
acid b-oxidation (e.g., CPT1, PGC1a, LCAD, and MCAD), and2024 Cell Reports 17, 2015–2027, November 15, 2016VLDL secretion (e.g., ApoB and MTP) was similar between
AKO and Snail1flox/flox mice (Figure 7E). As expected, no differ-
ences in liver ATGL or Snail1 protein levels were detected
between Snail1flox/flox and AKO mice (Figure S4E). Together,
these data suggest that loss of adipocyte Snail1 leads to liver
steatosis as a consequence of increased adipose lipolysis and
subsequent mobilization of fatty acids from adipose tissue to
the liver.
DISCUSSION
Herein, we have identified a previously unknown Snail1-ATGL
axis that controls adipocyte size and adiposity while playing an
equally important role in fatty acid partitioning between adipose
tissue and the liver.
Insulin is an essential anabolic hormone that increases adi-
pose TAG storage, in part by suppressing ATGL-mediated lipol-
ysis. While multiple mechanisms likely allow insulin to control
ATGL expression, we observed that adipose Snail1 levels posi-
tively correlated with insulin levels and body weights. Consistent
with this finding, insulin stimulation increased Snail1 mRNA and
protein levels in both mouse adipocytes and eWAT as well as
human adipose stem cell-derived adipocytes. In addition to
stimulating Snail1 expression, insulin may also increase Snail1
protein stability by suppressing GSK3a/b, as these kinases can
directly phosphorylate Snail1, thereby promoting its ubiquitina-
tion and degradation (Yook et al., 2005; Zhou et al., 2004).
Further, we found that Snail1 bound to the ATGL promoter and
directly suppressed ATGL expression, at least in part by eliciting
repressive epigenetic modifications of the ATGL promoter. As
Snail1 overexpression decreased lipolysis in adipocytes while
adipocyte-specific deletion of Snail1 markedly increased lipol-
ysis, Snail1-dependent epigenetic reprograming of ATGL, and
possibly additional metabolic gene products, likely impacts the
regulation of lipolysis in chronic overnutrition states. Thus, our
findings define a previously unknown adipose tissue insulin-
Snail1-ATGL-lipolysis axis that operates to control metabolic
regulation in vivo.
We also observed that Snail1 suppressed the expression of
PPARg, conforming the previous findings (Lee et al., 2013).
PPARg is known to stimulate ATGL expression (Kershaw et al.,
2006; Kim et al., 2006), raising the possibility that adipose Snail1
may inhibit ATGL expression indirectly via regulating PPARg.
Additionally, it may also regulate other aspects of adipose meta-
bolism through PPARg. As FoxO1 and Egr1 have been reported
to bind to the ATGL promoter and participate in mediating insulin
suppression of ATGL expression (Bartness et al., 2014; Chakra-
barti and Kandror, 2009; Chakrabarti et al., 2013), insulin may
suppress ATGL expression by multiple pathways. While addi-
tional studies are needed to determine the relative contributions
of Snail1, PPARg, FoxO1, and Egr1 pathways in regulating ATGL
expression and lipolysis, particularly in the setting of obesity, our
studies directly define a key role for adipocyte Snail1 in regu-
lating ATGL activity in vitro as well as in vivo.
The Snail1-ATGL-lipolysis axis characterized herein is
required for the maintenance of normal adipocyte size and
adiposity. Adipocyte-specific deletion of Snail1 resulted in a
reduction in both adipocyte size and whole-body fat mass in
mice, accompanied by increased ATGL-mediated lipolysis.
Adipose Snail1 levels were higher in obesity and inversely corre-
lated with ATGL expression, suggesting that elevated adipose
Snail1 levels promote adipocyte hypertrophy in obesity at least
in part by inhibiting ATGL expression. WAT-derived FFAs are
believed to be an important lipid source for liver steatosis during
NAFLD progression (Schoiswohl et al., 2015;Wilson et al., 2016),
and in this regard, it is noteworthy that AKO mice displayed
spontaneous lipid accumulation in the liver while the severity of
HFD-induced liver steatosis was increased in AKO mice. These
observations demonstrate that the adipose Snail1-ATGL-lipol-
ysis axis plays a critical role in the maintenance of normal lipid
partitioning between WAT and the liver. By suppressing ATGLexpression, Snail1 increases TAG storage capacity of WATwhile
decreasing FFA release, thereby protecting against improper
lipid partitioning, ectopic lipid accumulation, and lipotoxicity in
non-adipose tissues.
The role of adipose ATGL in glucose metabolism is complex,
as revealed by the observations that both adipocyte-specific
overexpression and deletion of ATGL similarly improve insulin
resistance and glucose intolerance in mice (Ahmadian et al.,
2009; Schoiswohl et al., 2015). We did not, however, detect dif-
ferences in glucose and insulin tolerance between AKO and
Snail1f/f mice fed either a normal chow diet or an HFD. Thus,
additional studies are warranted to examine the role of Snail1
in glucose metabolism. Nevertheless, our findings highlight a
heretofore unrecognized ability of adipose Snail1 to act as a
molecular brake that serves to regulate lipolysis and fatty acid
mobilization between adipose and non-adipose tissues.
EXPERIMENTAL PROCEDURES
Animals
Animal experiments were conducted following the protocols approved by the
University of Michigan Institutional Animal Care and Use Committee (IACUC).
Mice were housed on a 12-hr light/12-hr dark cycle in the Unit for Laboratory
Animal Medicine at the University of Michigan (ULAM) and fed either a stan-
dard chow diet (9% fat; Lab Diet) or an HFD (60% fat; Research Diets).
Plasma FFA, Glycerol, and Insulin Levels
Mice were fasted overnight or injected intraperitoneally with CL316243. Blood
samples were collected from tail veins. Plasma FFA and glycerol levels were
measured using NEFA-HR reagents (Wako Chemicals) and free glycerol re-
agents (Sigma, F6428), respectively. Insulin levels were measured using a
rat insulin ELISA kit (Crystal Chem).
Preparation of EMSCs, SVFs, and Primary Adipocytes
Ears were pooled from three mice, submerged in 70% ethanol for 2 min,
washed with sterile Hanks’ balanced salt solution (HBSS; Invitrogen, 14025-
092), andminced into small pieces in sterile HBSS supplemented with collage-
nase type II (1.66 mg/mL). Ear tissues were digested for 1 hr at 37C, filtered
through a 70-mm cell strainer (BD Biosciences, 352350), and centrifuged at
1,350 rpm for 8 min. Cell pellets were resuspended in red blood cell lysing
buffer (Sigma) and centrifuged again. EMSCs (cell pellets) were resuspended
and grown in DMEM/F12 (Invitrogen, 11330-032) supplementedwith 10% fetal
bovine serum (FBS) and 0.2% primocin (Invivogen).
eWAT was minced in PBS containing 10 mMCaCl2 and digested at 37
C for
20 min in PBS containing 10 mM CaCl2, 1.5 U/mL collagenase D (Roche,
11088882001), and 2.4 U/mL dispase II (Roche, 4942078001). Tissue suspen-
sions were filtered through a 100-mm filter and centrifuged at 200 g for 5 min.
Primary adipocytes (top floating fractions) and SVFs (pellets) were collected.
SVFs were resuspended and washed in PBS containing 10 mM CaCl2 and
2% FBS and grown in DMEM containing 25 mM glucose and 10% FBS.
Adipocyte Differentiation
3T3-L1 preadipocytes were maintained at 5% CO2 and 37
C in DMEM con-
taining 25 mM glucose and 8% calf serum. Confluent 3T3-L1 preadipocytes,
EMSCs, or SVFs were grown for additional 2 days and then cultured in a differ-
entiation cocktail (DMEM [3T3-L1] or DMEM/F12 [EMSCs and SVFs] contain-
ing 25 mM glucose, 10% FBS, 0.1 mM insulin, 1 mM dexamethasone [Sigma,
D-1756], 0.5 mM 3-isobutyl-1-methylxanthine [IBMX; Sigma, I-5879], and
0.1 mM rosiglitazone [Cayman Chemical Company]). Two days later, the cells
were grown in DMEM (3T3-L1) or DMEM/F12 (SVFs) supplemented with 10%
FBS and 0.1 mM insulin for additional 2 days and then maintained in DMEM
(3T3-L1) or DMEM/F12 (SVFs) containing 10% FBS.
Human adipose stem cells (#hASC-01) were purchased from the LaCell LLC
and grown in StromalMedium (LaSM) (LaCell LLC). Confluent cells were grownCell Reports 17, 2015–2027, November 15, 2016 2025
for 3 days in a differentiationmedium (DMEM/F12 supplementedwith 3%FBS,
0.5mM IBMX, 1 mMdexamethasone, 200 nM insulin, 5 mM rosiglitazone, 33 mM
biotin, and 17 mMd-pantothenate) and then in amaintenancemedium (DMEM/
F12 supplemented with 3% FBS, 1 mMdexamethasone, 200 nM insulin, 33 mM
biotin, and 17 mM d-pantothenate) for additional 6 days. Human adipocytes
were starved for 16 hr in DMEM/F12 supplemented with 0.6% BSA and then
stimulated with insulin (100 nM) for 5 hr.
Lipolysis Assays
eWAT wasminced into small pieces (1–2mm) in cold PBS. Fat explants (five or
six pieces) were incubated at 37C for 2 hr in KRH buffer (136 mM NaCl,
4.7 mM KCl, 1.25 mM MgSO4, 1.25 mM CaCl2, 20 mM HEPES [pH 7.4], and
2% BSA) and then stimulated with isoproterenol (1 mM). 3T3-L1, EMSC-
derived, or SVF-derived adipocytes were incubated in KRH buffer for 3 hr
and then stimulated with isoproterenol (1 mM). FFA and glycerol, which were
released from adipocytes into KRH buffer, were measured and normalized
to total adipocyte protein levels.
Liver TAG and Cholesterol Levels
Liver samples were homogenized in 1% acetic acid and extracted using 80%
chloroform/methanol (2:1). Lipids (organic phase) were transferred to a new
tube, dried by evaporation in a chemical hood, resuspended in 3M KOH, incu-
bated at 70C for 1 hr, mixed with MgCl2 (0.75 M), and centrifuged. The
aqueous fractions were used to measure TAG levels using free glycerol re-
agents (Sigma, F6428). Liver lipids were suspended in isopropanol and used
to measure cholesterol using a kit (Pointe Scientific, C7510).
ATGL Luciferase Reporter Assays
The murine ATGL promoter (from985 to +71) was prepared by PCR (forward
primer, 50-AGTGCCTCTCATGTATGCTTAA-30; reverse primer, 50-TCCCGC
AGTCTCGATACCTTGG-30 ) and inserted into pGL3 vectors at XhoI and HindIII
sites. The three putative Snail1 binding sites were replaced with ‘‘CTAATG’’ to
generate D1, D2, D3, or D123 luciferase reporters using site-directed muta-
genesis kits (Stratagene). ATGL luciferase reporter plasmids were cotrans-
fected with Snail1 expression vectors into HEK293 or 3T3-L1 cells (Jiang
et al., 2015b). Luciferase activities were measured 48 hr after transfection
using a kit (Promega) and normalized to the activities of coexpressed b-gal
(internal control).
Chromatin Immunoprecipitation
3T3-L1 adipocytes were treated with 1% formaldehyde for 15 min and lysed in
a lysis buffer (1% SDS 5 mM EDTA, 50 mM Tris-HCl, and protease inhibitor
cocktail [pH 7.9]). Genomic DNA was sheared to 200-bp to 1,000-bp frag-
ments using a sonic dismembrator (model Q800R, QSONICA). Female mice
(12 weeks) were fed an HFD for 8 weeks. Gonadal WAT (200 mg) was isolated,
minced on ice, and incubated with 1.5% formaldehyde for 20 min. WAT was
homogenized in hypotonic buffer (20 mM HEPES, 1 mM EDTA, 1 mM
EGTA,0.2% Triton X-100, and protease inhibitor cocktail [pH 7.9]). Nuclei
were isolated by centrifugation (13,500 rpm for 30 s), and genomic DNA was
sheared to 200-bp to 1,000-bp fragments. DNA-protein complexes were
immunoprecipitated with antibody against Snail1 or H3K9ac or normal rabbit
immunoglobulin G (IgG) (control). DNA was purified after reversing crosslink
and used to measure Snail1 occupancy and H3K9ac levels in the ATGL pro-
moter using qPCR. Antibodies and primers are listed in Tables S1 and S2,
respectively.
Immunoblotting
Tissues or cells were homogenized in a lysis buffer (50 mM Tris HCl [pH 7.5],
1.0% NP-40, 150 mM NaCl, 2 mM EGTA, 1 mM Na3VO4, 100 mM NaF,
10 mM Na4P2O7, 1 mM PMSF, 10 mg/mL aprotinin, and 10 mg/mL leupeptin)
(Chen et al., 2012). Tissue or cell extracts were immunoblotted with the indi-
cated antibodies. Antibodies are listed in Table S1.
Real-Time qPCR Analysis
Total RNAswere extracted using TRIzol reagent (Invitrogen Life Technologies).
The first-strand cDNAs were synthesized using random primers and M-MLV
reverse transcriptase (Promega). The abundance of mRNA was measured us-2026 Cell Reports 17, 2015–2027, November 15, 2016ing Radiant SYBR Green 2X Hi-ROX qPCR kits (Alkali Scientific) and the
Mx3000P real-time PCR system (Stratagene). Primers are listed in Table S2.
Nile Red Staining
Liver frozen sections (7 mm) were prepared using a Leica cryostat (Leica Bio-
systems), fixed in 4% paraformaldehyde for 30 min, stained with Nile red,
and visualized using a BX51microscope equipped with a DP72 Digital Camera
(Olympus).
Statistical Analysis
Data are presented as means ± SEM. Differences between groups were
analyzed by two-tailed Student’s t tests. p < 0.05 was considered statistically
significant.
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